CN102727683A - Traditional Chinese medicine for treating fatty liver - Google Patents
Traditional Chinese medicine for treating fatty liver Download PDFInfo
- Publication number
- CN102727683A CN102727683A CN2012102291445A CN201210229144A CN102727683A CN 102727683 A CN102727683 A CN 102727683A CN 2012102291445 A CN2012102291445 A CN 2012102291445A CN 201210229144 A CN201210229144 A CN 201210229144A CN 102727683 A CN102727683 A CN 102727683A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- chinese medicine
- fatty liver
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 21
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 20
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 20
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 20
- 241000195474 Sargassum Species 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims description 11
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000003908 liver function Effects 0.000 abstract description 2
- 241001648835 Polygonum cuspidatum Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 238000002651 drug therapy Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine for treating fatty liver, which is prepared from the following active pharmaceutical ingredients in parts by weight: 15-25 of salvia miltiorrhiza, 25-35 of sargassum, 20-30 of radix bupleuri, 15-25 of semen cassiae, 10-15 of polygonum cuspidatum and 20-30 of rhizoma alismatis. The traditional Chinese medicine has the efficacies of lowering lipid level, recovering the liver function and retracting the liver.
Description
Technical field:
The invention belongs to the field of Chinese medicines, particularly a kind of Chinese medicine of treating fatty liver.
Background technology:
Fatty liver is meant because the pathological changes of fatty overheap in the hepatocyte that causes of a variety of causes.The positive serious threat compatriots' of fatty liver disease health becomes the second largest hepatopathy that is only second to viral hepatitis, has been acknowledged as the common cause of disguised liver cirrhosis.Fatty liver is a kind of common clinical picture, but not a kind of independently disease.The lighter is asymptomatic in its clinical manifestation, and weight person's state of an illness is violent.Generally speaking, fatty liver belongs to the reversibility disease, and early diagnosis and treatment in time often can recover normal.Up to the present, Western medicine does not still have lipotropic active drug, and is best with the treatment of Chinese medicine long-time conditioning property, but treats the treatment by Chinese herbs overlong time of fatty liver at present, and curative effect is generally relatively poor.
Summary of the invention:
Comprehensively above-mentioned, in order to overcome the deficiency of prior art problem, it is simple that the present invention has developed a kind of configuration, the Chinese medicine of treatment fatty liver evident in efficacy.
The objective of the invention is to realize like this: a kind of Chinese medicine that is used to treat fatty liver comprises that following parts of medicines by weight is prepared from: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 15～25 parts by weight, 25～35 parts by weight, the Radix Bupleuri of 20～30 parts by weight, 15～25 parts by weight, the Rhizoma Polygoni Cuspidati of 10～15 parts by weight, the Rhizoma Alismatis of 20～30 parts by weight.
Technical scheme of the present invention can be achieved in that
A kind of Chinese medicine that is used to treat fatty liver comprises that following parts of medicines by weight is prepared from: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 20 parts by weight, 30 parts by weight, the Radix Bupleuri of 25 parts by weight, 20 parts by weight, the Rhizoma Polygoni Cuspidati of 12 parts by weight, the Rhizoma Alismatis of 25 parts by weight.
The present invention is ground into fine powder with each raw materials mix, directly takes, and every day three times, each 1-2 gram, warm water takes.
The course of treatment: 30 days is a course of treatment, need take the 3-5 course of treatment.
Pharmacology of the present invention and document are according to being:
Radix Salviae Miltiorrhizae: hardship is slightly cold; Effect: stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, relieving restlessness clears away heart-fire.
Sargassum: salty, cold; Effect: softening the hard mass, expectorant, diuretic, detumescent.
Radix Bupleuri: hardship is slightly cold; Effect: reconciling superficies and interior, soothing the liver, yang invigorating.
Semen Cassiae: sweet, bitter, salty, be slightly cold; Effect: clearing away heat to improve acuity of vision, loosening bowel to relieve constipation.
Rhizoma Polygoni Cuspidati: hardship, cold; Effect: promoting blood circulation to remove blood stasis; Dispelling wind and removing obstruction in the collateral; Clearing away heat-damp and promoting diuresis.
Rhizoma Alismatis: sweet light, cold; Effect: promoting diuresis to eliminate damp pathogen; It is treating stranguria to expel the heat-evil.
Radix Salviae Miltiorrhizae, the Rhizoma Polygoni Cuspidati clots absorbing collateral dredging of dispelling of invigorating blood circulation among the present invention, the expectorant of Sargassum softening the hard mass, the Radix Bupleuri depressed liver-energy dispersing and QI regulating, the Semen Cassiae liver heat removing through heat, bring high blood pressure down and serum cholesterol Rhizoma Alismatis nourishing YIN and dispelling dampness, and the effect of blood fat reducing is arranged.
Beneficial effect of the present invention:
The present invention is formulated with pure Chinese medicine, and scientific formulation is reasonable, and configuration is simple, has no side effect, and curative effect is short, and instant effect has the effect of blood fat reducing, recovering liver function, retraction liver.
The specific embodiment:
Below in conjunction with embodiment the present invention is explained further details:
Embodiment 1: a kind of Chinese medicine that is used to treat fatty liver comprises that the medication preparation of following weight in grams number forms: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 20 grams, 30 grams, the Radix Bupleuri of 25 grams, 20 grams, the Rhizoma Polygoni Cuspidati of 12 grams, the Rhizoma Alismatis of 25 grams.
Embodiment 2: a kind of Chinese medicine that is used to treat fatty liver comprises that the medication preparation of following weight in grams number forms: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 25 grams, 35 grams, the Radix Bupleuri of 30 grams, 25 grams, the Rhizoma Polygoni Cuspidati of 15 grams, the Rhizoma Alismatis of 30 grams.
Embodiment 3: a kind of Chinese medicine that is used to treat fatty liver comprises that the medication preparation of following weight in grams number forms: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 15 grams, 25 grams, the Radix Bupleuri of 20 grams, 15 grams, the Rhizoma Polygoni Cuspidati of 10 grams, the Rhizoma Alismatis of 20 grams.
Embodiment 4: a kind of Chinese medicine that is used to treat fatty liver comprises that the medication preparation of following weight in grams number forms: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 18 grams, 34 grams, the Radix Bupleuri of 26 grams, 22 grams, the Rhizoma Polygoni Cuspidati of 13 grams, the Rhizoma Alismatis of 24 grams.
Chinese medicine among the embodiment 1-4 with each raw materials mix, is ground into fine powder in the preparation, directly takes, and every day three times, each 1-2 gram takes with warm water.
The present invention is not limited to above-mentioned preferred forms, and other any identical with the present invention or akin products that anyone draws under enlightenment of the present invention all drop within protection scope of the present invention.
The result of clinical observation of the present invention is following:
Criterion of therapeutical effect:
Cure: in the patient's transference cure, liver total fat mass be no more than liver heavy 5%.
Effectively: patient's symptom makes moderate progress, but does not reach arm's length standard.
Invalid: through a period of time treatment, patient's blood pressure does not have any improvement.
Curative effect of medication is observed situation:
Drug therapy 134 people of the present invention, healing person 102 people, responder 17 people, nonresponder 15 people, effective percentage 88%.
Model case:
Money: the man, 55 years old, people from Xinzheng, Henan, lassitude and weak during prescription on individual diagnosis, right rib place has a dull ache, after the here Drug therapy, 30 days take effect, recovery from illness in three months.
Zhao: the woman, 47 years old, people from Xuchang, Henan suffered from fatty liver 2 years, and inappetence is felt sick, is vomitted, after the here Drug therapy, one and a half months takes effect, recovery from illness in three months.
Poplar: the man, 42 years old, table mountain Weidong District people suffered from fatty liver 3 years, during take other drug treatment, but poor effect, after the here Drug therapy, bimester, take effect, recovery from illness in four months.
Zhang: the woman, 37 years old, people from Handan, Hebei suffered from fatty liver 7 years, after the here Drug therapy, two months take effect, recovery from illness in five months.
Claims (2)
1. a Chinese medicine that is used to treat fatty liver is characterized in that: comprise that following parts of medicines by weight is prepared from: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 15～25 parts by weight, 25～35 parts by weight, the Radix Bupleuri of 20～30 parts by weight, 15～25 parts by weight, the Rhizoma Polygoni Cuspidati of 10～15 parts by weight, the Rhizoma Alismatis of 20～30 parts by weight.
2. the Chinese medicine that is used to treat fatty liver according to claim 1 is characterized in that: comprise that following parts of medicines by weight is prepared from: the Semen Cassiae of the Sargassum of the Radix Salviae Miltiorrhizae of 20 parts by weight, 30 parts by weight, the Radix Bupleuri of 25 parts by weight, 20 parts by weight, the Rhizoma Polygoni Cuspidati of 12 parts by weight, the Rhizoma Alismatis of 25 parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210229144.5A CN102727683B (en) | 2012-07-04 | 2012-07-04 | Traditional Chinese medicine for treating fatty liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210229144.5A CN102727683B (en) | 2012-07-04 | 2012-07-04 | Traditional Chinese medicine for treating fatty liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102727683A true CN102727683A (en) | 2012-10-17 |
| CN102727683B CN102727683B (en) | 2014-06-25 |
Family
ID=46984447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210229144.5A Expired - Fee Related CN102727683B (en) | 2012-07-04 | 2012-07-04 | Traditional Chinese medicine for treating fatty liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727683B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1524552A (en) * | 2003-02-27 | 2004-09-01 | 上海方心科技研究所 | Chinese medicine preparation for treating fatty liver |
| CN102488798A (en) * | 2011-12-13 | 2012-06-13 | 广州中医药大学 | Medicine for treating non-alcoholic fatty liver |
-
2012
- 2012-07-04 CN CN201210229144.5A patent/CN102727683B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1524552A (en) * | 2003-02-27 | 2004-09-01 | 上海方心科技研究所 | Chinese medicine preparation for treating fatty liver |
| CN102488798A (en) * | 2011-12-13 | 2012-06-13 | 广州中医药大学 | Medicine for treating non-alcoholic fatty liver |
Non-Patent Citations (1)
| Title |
|---|
| 范杰华 等.: "降脂复肝汤治疗脂肪肝疗效观察", 《光明中医》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102727683B (en) | 2014-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102357187B (en) | Traditional Chinese medicine composition for treating acute lumbar sprain | |
| CN103705603B (en) | Traditional Chinese medicine for treating acne | |
| CN104667244A (en) | Foot bath composition for treating primary dysmenorrheal | |
| CN103417790B (en) | Traditional Chinese medicine for treatment of cerebral hemorrhage | |
| CN103784890B (en) | A kind of Chinese medicine composition for the treatment of osteopathia | |
| CN103211942B (en) | Chinese medicament for treating acute conjunctivitis | |
| CN102406808A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN103120738A (en) | Medicinal composition for treating ischemic cerebral apoplexy | |
| CN103041271B (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN104721614A (en) | Traditional Chinese medicine preparation for treating dearticulation and preparation method of traditional Chinese medicine preparation | |
| CN102327524A (en) | Traditional Chinese medicine composition for curing erysipelas | |
| CN103169855A (en) | Drug composition for treating chronic heart failure | |
| CN102727683B (en) | Traditional Chinese medicine for treating fatty liver | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN103948713A (en) | Traditional Chinese medicinal composition for treating hypertension | |
| CN104383200A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea and preparation method of traditional Chinese medicine preparation | |
| CN103948763A (en) | Traditional Chinese medicinal composition for treating hepatosis | |
| CN103845690A (en) | Medicament for treating geriatric depression | |
| CN102327451A (en) | Chinese medicinal composition for treating chronic sinusitis | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN102366510A (en) | Traditional Chinese medicine for treating hypercortisolism | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN106038964A (en) | Traditional Chinese medicine composition for treating acute lumbar sprain | |
| CN106138415A (en) | A kind of Chinese medicine composition of the femur head necrosis caused for a variety of causes | |
| CN105726849B (en) | It is a kind of for treating the Chinese medicine of diabetes Depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAIMEN ZHAOYANG INDUSTRY CO., LTD. Free format text: FORMER OWNER: XU RUIQIN Effective date: 20150610 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150610 Address after: Si Jia Zhen Ren Min Lu Haimen City 226100 Jiangsu city of Nantong province No. 438 Patentee after: HAIMEN MINGYANG INDUSTRIAL CO.,LTD. Address before: 467000 East worker Town, Weidong District, Henan, Pingdingshan Patentee before: Xu Ruiqin |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140625 |